Rush University Medical Center

 

Changing the Game in Lung Cancer Treatment: Precision Medicine in 2020
13:56

Rush University Medical Center's Changing the Game in Lung Cancer Treatment: Precision Medicine in 2020

ALKm NSCLC 1L Management Strategies: What ALK TKIs Are Available? How to Overcome Alectinib Resistance?

FEATURING Christine Lovly
  • 150 views
  • January 21, 2021
  • 1
19:03

Rush University Medical Center's Changing the Game in Lung Cancer Treatment: Precision Medicine in 2020

Driver Mutations in NSCLC: How Important Is Comprehensive Molecular Profiling? What Targeted Therapies Are Available? Which Combos to Use and When?

FEATURING Christine Lovly
  • 287 views
  • January 21, 2021
  • 3
16:29

Rush University Medical Center

Rush 2020 Clinical Trial Update on Thoracic Surgery: Is Sublobar Resection Equivalent to Lobectomy for the NSCLC?

FEATURING Christopher Seder
  • 17 views
  • October 15, 2020
07:57

Rush University Medical Center

Updates in Lung Cancer Screening: Will New USPTF Guidelines Expand Screening Eligibility?

FEATURING Linda Dowling
  • 362 views
  • October 13, 2020
  • 3
06:37

Rush University Medical Center

Rush Update on Lung Cancer Screening During COVID-19: What Are the Challenges and New Opportunities? Is Billing the Same for Telemedicine and In-Person Visits?

FEATURING Linda Dowling
  • 38 views
  • October 13, 2020
  • 1
15:08

Rush University Medical Center

Rush 2020 Update on Lung Cancer Diagnosis: Which Minimally Invasive Detection Methods Should We Use? What Is Digital Tomosynthesis and Cone Beam CT?

FEATURING James Katsis
  • 57 views
  • October 13, 2020
  • 1
19:34

Rush University Medical Center

Rush 2020 Update on Lung Cancer & ILD Treatment: Are Patients With ILD at Increased Risk of Complications for Cancer Treatment? How Effective Are Prophylactic Therapies?

FEATURING Mark Yoder
  • 122 views
  • October 13, 2020
  • 2
11:23

Rush University Medical Center's Changing the Game in Lung Cancer Treatment: Precision Medicine in 2020

Rush 2020 Updates on Lung Cancer Screening: How Does It Compare to Established Screening Modalities? What Are Mortality Rates in Volume CT Screening vs. No Screening?

FEATURING Justin Karush
  • 147 views
  • September 30, 2020
  • 2
32:14

Rush University Medical Center's Changing the Game in Lung Cancer Treatment: Precision Medicine in 2020

Rush 2020 Update on SBRT in Lung Cancer: What Is the Role of Aggressive Local Therapy for Oligomets? How Effective Is SBRT + Targeted/Immunotherapy?

FEATURING Gaurav Marwaha
  • 30 views
  • September 28, 2020
  • 1
13:53

Rush University Medical Center's Changing the Game in Lung Cancer Treatment: Precision Medicine in 2020

Rush 2020 Update on IO in 1L NSCLC: Is Single Agent PD-1 Antibody the Best First Choice for High PD-L1? What CPIs Are Best Option for Sparing Chemo? How Applicable Is Pembro Mono in Low PD-L1?

FEATURING Mary Fidler
  • 418 views
  • September 25, 2020
  • 3